2026-04-17T16:08:03Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4791652025-10-05T13:25:34Zcom_2072_98col_2072_378192

/ore.xml RECERCAT The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy Jimenez-Fonseca, Paula Foy, Victoria Raby, Sophie Carmona-Bayonas, Alberto Macía-Rivas, Lola Arrazubi, Virginia Cacho Lavin, Diego Hernandez San Gil, Raquel Custodio, Ana Cano, Juana María Fernández Montes, Ana Mirallas, Oriol Macias Declara, Ismael Vidal Tocino, Rosario Visa, Laura Limón, María Luisa Pimentel, Paola Martínez Lago, Nieves Saurí Nadal, Tamara Martín Richard, Marta Mangas, Monserrat Gil Raga, Mireia Calvo, Aitana Reguera, Pablo Granja, Mónica Martín Carnicero, Alfonso Hernández Pérez, Carolina Cerdà, Paula Gomez Gonzalez, Lucía Garcia Navalon, Francisco Pacheco-Barcia, Vilma Gutierrez Abad, David Ruiz Martín, Maribel Weaver, Jamie Mansoor, Wasat Gallego, Javier Universitat Autònoma de Barcelona